Broggini M - Search Results

1

Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth.

Cisse O, Quraishi M, Gulluni F, Guffanti F, Mavrommati I, Suthanthirakumaran M, Oh LCR, Schlatter JN, Sarvananthan A, Broggini M, Hirsch E, Falasca M, Maffucci T. Cisse O, et al. Among authors: broggini m. J Exp Clin Cancer Res. 2019 Nov 21;38(1):472. doi: 10.1186/s13046-019-1472-9. J Exp Clin Cancer Res. 2019. PMID: 31752944 Free PMC article.

2

p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth.

Bonfanti M, Taverna S, Salmona M, D'Incalci M, Broggini M. Bonfanti M, et al. Among authors: broggini m. Cancer Res. 1997 Apr 15;57(8):1442-6. Cancer Res. 1997. PMID: 9108443

3

Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines.

Razzini G, Berrie CP, Vignati S, Broggini M, Mascetta G, Brancaccio A, Falasca M. Razzini G, et al. Among authors: broggini m. FASEB J. 2000 Jun;14(9):1179-87. doi: 10.1096/fasebj.14.9.1179. FASEB J. 2000. PMID: 10834940

4

4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.

Marchini S, Damia G, Broggini M, Pennella G, Ripamonti M, Marsiglio A, Geroni C. Marchini S, et al. Among authors: broggini m. Cancer Res. 2001 Mar 1;61(5):1991-5. Cancer Res. 2001. PMID: 11280757

5

Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.

Geroni C, Marchini S, Cozzi P, Galliera E, Ragg E, Colombo T, Battaglia R, Howard M, D'Incalci M, Broggini M. Geroni C, et al. Among authors: broggini m. Cancer Res. 2002 Apr 15;62(8):2332-6. Cancer Res. 2002. PMID: 11956092

6

Inositol pentakisphosphate promotes apoptosis through the PI 3-K/Akt pathway.

Piccolo E, Vignati S, Maffucci T, Innominato PF, Riley AM, Potter BV, Pandolfi PP, Broggini M, Iacobelli S, Innocenti P, Falasca M. Piccolo E, et al. Among authors: broggini m. Oncogene. 2004 Mar 4;23(9):1754-65. doi: 10.1038/sj.onc.1207296. Oncogene. 2004. PMID: 14755253

7

Improving the selectivity of cancer treatments by interfering with cell response pathways.

Damia G, Broggini M. Damia G, et al. Among authors: broggini m. Eur J Cancer. 2004 Nov;40(17):2550-9. doi: 10.1016/j.ejca.2004.07.020. Eur J Cancer. 2004. PMID: 15541958 Review.

8

Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects.

Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M. Maffucci T, et al. Among authors: broggini m. Cancer Res. 2005 Sep 15;65(18):8339-49. doi: 10.1158/0008-5472.CAN-05-0121. Cancer Res. 2005. PMID: 16166311

9

PRL-3 phosphatase is implicated in ovarian cancer growth.

Polato F, Codegoni A, Fruscio R, Perego P, Mangioni C, Saha S, Bardelli A, Broggini M. Polato F, et al. Among authors: broggini m. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6835-9. doi: 10.1158/1078-0432.CCR-04-2357. Clin Cancer Res. 2005. PMID: 16203771

10

In vivo evaluation of the role of DNp73alpha protein in regulating the p53-dependent apoptotic pathway after treatment with cytotoxic drugs.

Sabatino MA, Previdi S, Broggini M. Sabatino MA, et al. Among authors: broggini m. Int J Cancer. 2007 Feb 1;120(3):506-13. doi: 10.1002/ijc.22362. Int J Cancer. 2007. PMID: 17096333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters